Exome Asset Management

资产管理

Verified investment lower bound≥$1.98M

Investment cases1

Manager operating history—

Representative investments

Individual transactions and cumulative snapshots use different bases. Do not add these rows again to cumulative totals.

Date	Company	Round	Original-currency amount	Paying entity	Specific funds	Sources
2025-12-30	Insilico Medicine（英矽智能）	IPO最终获配认购	HKD 15.56M	Emerging Markets Healthcare Partners LLC	Emerging Markets Healthcare Partners LLC	Sources · 2 英矽智能2025最终配售结果：第5–12页机构获配及最终发行价 ↗2026-10-24 英矽智能招股书：第212–217、362–369页机构、基金与控制关系 ↗2026-10-24 Basis and notes 基石647,000股＋额外国际配售0股，合计647,000股×HK$24.05。按最终配售计算认购款，不含费用，不声称银行流水已核。上市日为交易事件日期，非银行付款日。美元仅使用本站既有汇率快照；不是按当前股价计算。